ImmunityBio raises $75 million in equity financing

ImmunityBio ( NASDAQ: IBRX ) on Tuesday announced that it has signed a securities purchase agreement for a registered direct offering with a single institutional investor, providing for the issuance of common stock of ImmunityBio as well as warrants for the purchase of.